156 related articles for article (PubMed ID: 37921267)
1. Association between gut microbial change and acute gastrointestinal toxicity in patients with prostate cancer receiving definitive radiation therapy.
Jang BS; Chung MG; Lee DS
Cancer Med; 2023 Nov; 12(22):20727-20735. PubMed ID: 37921267
[TBL] [Abstract][Full Text] [Related]
2. Can Anorectal Manometry Findings Predict Subsequent Late Gastrointestinal Radiation Toxicity in Prostate Cancer Patients?
Choi Y; Park W; Rhee PL
Cancer Res Treat; 2016 Jan; 48(1):297-303. PubMed ID: 25779364
[TBL] [Abstract][Full Text] [Related]
3. The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review.
Oh B; Eade T; Lamoury G; Carroll S; Morgia M; Kneebone A; Hruby G; Stevens M; Boyle F; Clarke S; Corless B; Molloy M; Rosenthal D; Back M
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068216
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial.
Ma TM; Ballas LK; Wilhalme H; Sachdeva A; Chong N; Sharma S; Yang T; Basehart V; Reiter RE; Saigal C; Chamie K; Litwin MS; Rettig MB; Nickols NG; Yoon SM; Smith L; Gao Y; Steinberg ML; Cao M; Kishan AU
Int J Radiat Oncol Biol Phys; 2023 Jan; 115(1):142-152. PubMed ID: 36007724
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy.
Feng M; Hanlon AL; Pisansky TM; Kuban D; Catton CN; Michalski JM; Zelefsky MJ; Kupelian PA; Pollack A; Kestin LL; Valicenti RK; DeWeese TL; Sandler HM
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1417-23. PubMed ID: 17418972
[TBL] [Abstract][Full Text] [Related]
6. Prospective Phase II Trial of Once-weekly Hypofractionated Radiation Therapy for Low-risk Adenocarcinoma of the Prostate: Late Toxicities and Outcomes.
Zimmermann M; Taussky D; Menkarios C; Vigneault É; Beauchemin MC; Bahary JP; Martin AA; Diaz de Bedoya LV; Lambert C
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):386-92. PubMed ID: 26782838
[TBL] [Abstract][Full Text] [Related]
7. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer.
Mitra A; Grossman Biegert GW; Delgado AY; Karpinets TV; Solley TN; Mezzari MP; Yoshida-Court K; Petrosino JF; Mikkelson MD; Lin L; Eifel P; Zhang J; Ramondetta LM; Jhingran A; Sims TT; Schmeler K; Okhuysen P; Colbert LE; Klopp AH
Int J Radiat Oncol Biol Phys; 2020 May; 107(1):163-171. PubMed ID: 31987960
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
9. High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experience.
Detti B; Baki M; Becherini C; Saieva C; Scartoni D; Giacomelli I; Trombetta L; Muntoni C; Olmetto E; Francolini G; Turkaj A; Topulli J; Ciabatti C; Carta G; Poggesi L; Delli Paoli C; Terziani F; Grassi R; Livi L
Radiol Med; 2019 May; 124(5):422-431. PubMed ID: 30607866
[TBL] [Abstract][Full Text] [Related]
10. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
Lewis SL; Patel P; Song H; Freedland SJ; Bynum S; Oh D; Palta M; Yoo D; Oleson J; Salama JK
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):605-11. PubMed ID: 26867889
[TBL] [Abstract][Full Text] [Related]
11. Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.
Cheng JC; Schultheiss TE; Nguyen KH; Wong JY
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):351-7. PubMed ID: 18164841
[TBL] [Abstract][Full Text] [Related]
12. A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes.
Glicksman R; Sanmamed N; Thoms J; Zlotta AR; Finelli A; van der Kwast T; Sweet J; Jewett M; Klotz LH; Rosewall T; Fleshner NE; Bristow RG; Warde P; Berlin A
Int J Radiat Oncol Biol Phys; 2019 May; 104(1):61-66. PubMed ID: 30625410
[TBL] [Abstract][Full Text] [Related]
13. Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer.
Sveistrup J; Widmark A; Fransson P; Iversen P; Munck Af Rosenschöld P; Engelholm SA; Petersen PM
Scand J Urol; 2015 Feb; 49(1):58-69. PubMed ID: 24793783
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of post-prostatectomy radiotherapy at a Regional Cancer Centre.
Nicholls L; Winter A; Harwood A; Plank A; Bagga P; Wong W; Khoo E
J Med Radiat Sci; 2017 Dec; 64(4):259-265. PubMed ID: 28805047
[TBL] [Abstract][Full Text] [Related]
15. Comparison and limitations of DVH-based NTCP models derived from 3D-CRT and IMRT data for prediction of gastrointestinal toxicities in prostate cancer patients by using propensity score matched pair analysis.
Troeller A; Yan D; Marina O; Schulze D; Alber M; Parodi K; Belka C; Söhn M
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):435-43. PubMed ID: 25636766
[TBL] [Abstract][Full Text] [Related]
16. Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy.
Pearse M; Choo R; Danjoux C; Gardner S; Morton G; Szumacher E; Loblaw A; Cheung P
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):792-8. PubMed ID: 18707818
[TBL] [Abstract][Full Text] [Related]
17. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.
Yeoh EE; Fraser RJ; McGowan RE; Botten RJ; Di Matteo AC; Roos DE; Penniment MG; Borg MF
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):943-55. PubMed ID: 12605972
[TBL] [Abstract][Full Text] [Related]
18. Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy.
Beck M; Wust P; Barelkowski T; Kaul D; Thieme AH; Wecker S; Wlodarczyk W; Budach V; Ghadjar P
Radiat Oncol; 2017 Aug; 12(1):125. PubMed ID: 28793907
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported quality of life during definitive and postprostatectomy image-guided radiation therapy for prostate cancer.
Diao K; Lobos EA; Yirmibesoglu E; Basak R; Hendrix LH; Barbosa B; Miller SM; Pearlstein KA; Goldin GH; Wang AZ; Chen RC
Pract Radiat Oncol; 2017; 7(2):e117-e124. PubMed ID: 28274402
[TBL] [Abstract][Full Text] [Related]
20. Late gastrointestinal toxicity after radiation for prostate cancer.
Giordano SH; Lee A; Kuo YF; Freeman J; Goodwin JS
Cancer; 2006 Jul; 107(2):423-32. PubMed ID: 16779795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
